A pan-cancer analysis of 1661 cancer patients across 11 different solid tumor types treated with PD-1/PD-L1 therapy confirmed that the presence of liver metastases was associated with a significantly shorter OS (9 vs. 15 months, HR 1.79, p < 0.0001). The gene discussed is CD274; the disease is cancer.